We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CELLAVISION AB

CellaVision AB provides digital solutions for medical microscopy in the field of hematology, with its product portfol... read more Featured Products: More products

Download Mobile App





CellaVision Displays New DIFF-Line Workflow Solution for Low-Volume Hematology Laboratories

By LabMedica International staff writers
Posted on 24 Jul 2023
Print article
Image: The new DIFF-Line complete workflow solution for low-volume hematology laboratories is on display at AACC 2023 (Photo courtesy of CellaVision)
Image: The new DIFF-Line complete workflow solution for low-volume hematology laboratories is on display at AACC 2023 (Photo courtesy of CellaVision)

CellaVision (Lund, Sweden) is attending AACC 2023 where the company is showcasing some of its latest products, including its new DIFF-Line complete workflow solution for low-volume hematology laboratories. Advancing into the area of digital bone marrow analysis, CellaVision is also sharing a preview of its upcoming bone marrow application.

DIFF-Line by CellaVision is a complete workflow for smearing, staining, and analyzing peripheral blood smears in hematology labs that handle a smaller amount of daily blood samples. DIFF-Line consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision DC-1, RAL SmearBox, and RAL StainBox. CellaVision DC-1 is a single-slide analyzer that automates and digitizes the process of analyzing peripheral blood smears. The analyzer has an automated microscope, a high-quality digital camera, and an advanced computer system that uses artificial intelligence to locate, digitally capture, and pre-classify cells from stained blood smears. The pre-classified cells are presented on a computer screen for review and verification. The CellaVision DC-1 was launched in 2019 and received FDA clearance in October 2020.

RAL SmearBox produces high-quality peripheral blood smears. The automated instrument uses a patented consumable to produce smears directly from a closed whole sample tube. CellaVision introduced the RAL SmearBox to the market in 2022. RAL StainBox stains blood smears consistently and by laboratory guidelines. The semi-automated instrument utilizes the bath method and guides the laboratory through a step-by-step staining process. Improved staining protocols contribute to ease of use and optimized DC-1 performance. The RAL StainBox uses MCDh methanol-free stains to ensure high stain quality and reproducibility while reducing staff exposure to toxic chemicals.

Related Links:
CellaVision 

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: Picture of the setup used (Photo courtesy of G Puneeth/IISc)

Painless Technique Measures Glucose Concentrations in Solution and Tissue Via Sound Waves

Blood glucose levels are traditionally measured using invasive methods that require pricking the skin with small needles. However, for individuals with diabetes, frequent testing throughout the day becomes... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.